Innovator’s Pitch Challenge

Interested in Connecting? Please contact:

Milica Radisic
CEO
milica@quthero.com

Message the company or request a 1:1 meeting here

Company Description

Quthero Inc is an early-stage life sciences startup developing applications for our platform technology–a unique, patented, evolutionary-preserved Q-peptide technology that has been scientifically proven in 13 peer-reviewed publications to improve regeneration and reduce inflammation. Quthero is focused on two applications in dermatologic treatment–the $500M self-pay, post-beautifying procedures market to improve skin texture post-laser and post microneedling and the $10B surgical wound care market to eliminate scarring upon procedures such as breast augmentation, to enable 60-200% faster healing than leading treatments. In an IRB-approved double-blinded multi-site clinical trial Quthero’s gel accelerated healing after radiofrequency microneedling and laser-face resurfacing by 2x.

Pitch Deck

Executive Summary